{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:46:16Z","timestamp":1761540376031},"reference-count":45,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The proinflammatory cytokine tumor necrosis factor alpha (TNF-\u03b1) induces lethal hepatitis when injected into<jats:sc>d<\/jats:sc>-(+)-galactosamine-sensitized mice on the one hand or systemic inflammatory response syndrome (SIRS) in normal mice on the other hand. We studied whether serum amyloid P component (SAP), the major acute-phase protein in mice, plays a protective role in both lethal models. For this purpose, we used SAP<jats:sup>0\/0<\/jats:sup>mice generated by gene targeting. We studied the lethal response of SAP<jats:sup>0\/0<\/jats:sup>or SAP<jats:sup>+\/+<\/jats:sup>mice to both lethal triggers but found no differences in the sensitivity of both types of mice. We also investigated whether SAP is involved in establishing two types of endogenous protection: one using a single injection of interleukin-1\u03b2 (IL-1\u03b2) for desensitization and clearly involving a liver protein, the other by tolerizing mice for 5 days using small doses of human TNF-\u03b1. Although after IL-1\u03b2 or after tolerization the SAP levels in the serum had risen fourfold in the control mice and not in the SAP<jats:sup>0\/0<\/jats:sup>mice, the same extents of desensitization and tolerization were achieved. Finally, we observed that the induction of hemorrhagic necrosis in the skin of mice by two consecutive local injections with TNF-\u03b1 was not altered in SAP<jats:sup>0\/0<\/jats:sup>mice. We conclude that the presence or absence of SAP has no influence on the sensitivity of mice to TNF-\u03b1-induced hepatitis, SIRS, and hemorrhagic necrosis or on the endogenous protective mechanisms of desensitization or tolerization.<\/jats:p>","DOI":"10.1128\/iai.68.9.5026-5029.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:03:59Z","timestamp":1027764239000},"page":"5026-5029","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["The Major Acute-Phase Protein, Serum Amyloid P Component, in Mice Is Not Involved in Endogenous Resistance against Tumor Necrosis Factor Alpha-Induced Lethal Hepatitis, Shock, and Skin Necrosis"],"prefix":"10.1128","volume":"68","author":[{"given":"Wim","family":"Van Molle","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tino","family":"Hochepied","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Brouckaert","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Libert","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1989.tb24021.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Beyaert R. Fiers W. Tumor necrosis factor and lymphotoxin Cytokines. Mire-Sluis A. R. Thorpe R. 1998 335 360 Academic Press Inc. San Diego Calif","DOI":"10.1016\/B978-012498340-3\/50025-7"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0897-855"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(86)90003-9"},{"key":"e_1_3_2_6_2","first-page":"167","article-title":"Tumor necrosis factor and the systemic inflammatory response syndrome","volume":"216","author":"Brouckaert P.","year":"1996","unstructured":"Brouckaert P. Fiers W. Tumor necrosis factor and the systemic inflammatory response syndrome.Curr. Top. Microbiol. Immunol.2161996167187","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.151.4.2087","article-title":"Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes","volume":"151","author":"Brown M. R.","year":"1993","unstructured":"Brown M. R. Anderson B. E. Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes.J. Immunol.151199320872095","journal-title":"J. Immunol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(89)80476-4"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00267953"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BFb0027661"},{"key":"e_1_3_2_11_2","first-page":"3899","article-title":"TNF-\u03b1 in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives","volume":"18","author":"Eggermont A. M.","year":"1998","unstructured":"Eggermont A. M. TNF-\u03b1 in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives.Anticancer Res.18199838993905","journal-title":"Anticancer Res."},{"key":"e_1_3_2_12_2","first-page":"579","article-title":"Early, reversible plasma membrane injury in galactosamine-induced liver cell death","volume":"3","author":"El-Mofty S. K.","year":"1975","unstructured":"El-Mofty S. K. Scrutton M. C. Serroni A. Nicolini C. Farber J. L. Early, reversible plasma membrane injury in galactosamine-induced liver cell death.Am. J. Pathol.31975579595","journal-title":"Am. J. Pathol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/367338a0"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.6.2110-2115.1991"},{"key":"e_1_3_2_15_2","first-page":"1","article-title":"Lethal shock in partially hepatectomized rats administered tumor necrosis serum","volume":"26","author":"Fukushima H.","year":"1988","unstructured":"Fukushima H. Ikeuchi J. Tohkin M. Matsubara T. Harada M. Lethal shock in partially hepatectomized rats administered tumor necrosis serum.Circ. Shock261988114","journal-title":"Circ. Shock"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.45.26950"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.1993.1012"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9673(95)00644-3"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.4049\/jimmunol.149.11.3689","article-title":"Serum amyloid P component binds to histones and activates the classical complement pathway","volume":"149","author":"Hicks P. S.","year":"1992","unstructured":"Hicks P. S. Saunero-Nava L. Du Clos T. W. Mold C. Serum amyloid P component binds to histones and activates the classical complement pathway.J. Immunol.149199236893694","journal-title":"J. Immunol."},{"key":"e_1_3_2_20_2","first-page":"817","article-title":"Tumour necrosis factor: clinical relevance","volume":"8","author":"Jones A. L.","year":"1989","unstructured":"Jones A. L. Selby P. Tumour necrosis factor: clinical relevance.Cancer Surveys81989817836","journal-title":"Cancer Surveys"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4800(68)90042-7"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.3.657"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4049\/jimmunol.153.4.1778","article-title":"Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-\u03b1 requires transcriptional arrest","volume":"153","author":"Leist M.","year":"1994","unstructured":"Leist M. Gantner F. Bohlinger I. Germann P. G. Tiegs G. Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-\u03b1 requires transcriptional arrest.J. Immunol.153199417781788","journal-title":"J. Immunol."},{"key":"e_1_3_2_24_2","first-page":"191","article-title":"Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma","volume":"43","author":"Lejeune F.","year":"1994","unstructured":"Lejeune F. Li\u00e9nard D. Eggermont A. Schraffordt Koops H. Kroon B. G\u00e9rain J. Rosenkaimer F. Schmitz P. Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma.Circ. Shock431994191197","journal-title":"Circ. Shock"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80226-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.4.1571"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240945"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199108000-00001"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.4049\/jimmunol.146.8.2625","article-title":"Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor","volume":"146","author":"Libert C.","year":"1991","unstructured":"Libert C. Van Bladel S. Brouckaert P. Shaw A. Fiers W. Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor.J. Immunol.146199126252632","journal-title":"J. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.4049\/jimmunol.157.11.5126","article-title":"\u03b11-Antitrypsin inhibits the lethal response to TNF in mice","volume":"157","author":"Libert C.","year":"1996","unstructured":"Libert C. Van Molle W. Brouckaert P. Fiers W. \u03b11-Antitrypsin inhibits the lethal response to TNF in mice.J. Immunol.157199651265129","journal-title":"J. Immunol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.1.52"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915814"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/278259a0"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.2.607"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.9.8.7768358"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1987.tb01073.x"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","unstructured":"Spriggs D. R. Yates S. W. Clinical studies of tumor necrosis factor in the USA Tumor necrosis factor: structure-function relationship and clinical application. Osawa T. Bonavida B. 1992 275 284 Karger Basel Switzerland","DOI":"10.1159\/000420793"},{"key":"e_1_3_2_38_2","first-page":"2366","article-title":"Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice","volume":"51","author":"Takahashi N.","year":"1991","unstructured":"Takahashi N. Brouckaert P. Fiers W. Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice.Cancer Res.51199123662372","journal-title":"Cancer Res."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910630616"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1003338"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.145.8.2507","article-title":"Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-\u03b2","volume":"145","author":"Taylor A. W.","year":"1990","unstructured":"Taylor A. W. Ku N. O. Mortensen R. F. Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-\u03b2.J. Immunol.145199025072513","journal-title":"J. Immunol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cb.09.110193.001533"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.159.7.3555","article-title":"\u03b11-Acid glycoprotein and \u03b11-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice","volume":"159","author":"Van Molle W.","year":"1997","unstructured":"Van Molle W. Libert C. Fiers W. Brouckaert P. \u03b11-Acid glycoprotein and \u03b11-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice.J. Immunol.159199735553564","journal-title":"J. Immunol."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.4049\/jimmunol.140.9.2994","article-title":"Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1","volume":"140","author":"Wallach D.","year":"1988","unstructured":"Wallach D. Holtmann H. Engelmann H. Nophar Y. Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1.J. Immunol.140198829942999","journal-title":"J. Immunol."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4049\/jimmunol.150.1.169","article-title":"Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q","volume":"150","author":"Ying S. C.","year":"1993","unstructured":"Ying S. C. Gewurz A. T. Jiang H. Gewurz H. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.J. Immunol.1501993169176","journal-title":"J. Immunol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(93)90192-R"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.9.5026-5029.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.9.5026-5029.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:45:13Z","timestamp":1682264713000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.68.9.5026-5029.2000"}},"subtitle":[],"editor":[{"given":"R. N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1128\/IAI.68.9.5026-5029.2000"],"URL":"https:\/\/doi.org\/10.1128\/iai.68.9.5026-5029.2000","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"2000-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-06-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}